drugset / Trial / NCT00750334
A Study of Oral Clofarabine in Adult Patients With Myelodysplastic Syndromes (MDS)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study will be used to determine the maximum tolerated dose of oral clofarabine when administered daily for 14 consecutive days repeated every 21 days.
Timeline
- Start
- 2008-09
- Primary completion
- 2008-10
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clofarabine | Other / unclassified | — | Oral |